vs
Side-by-side financial comparison of CALERES INC (CAL) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $790.1M, roughly 1.8× CALERES INC). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs 0.3%, a 1.1% gap on every dollar of revenue. On growth, CALERES INC posted the faster year-over-year revenue change (6.6% vs 6.4%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-12.4M). Over the past eight quarters, CALERES INC's revenue compounded faster (6.5% CAGR vs 2.8%).
Caleres Inc. is an American footwear company that owns and operates a variety of footwear brands. Its headquarters is located in Clayton, Missouri, a suburb of St. Louis. The company was founded in 1878 as Bryan, Brown & Company in St. Louis, though it underwent several name changes. The Hamilton-Brown Shoe Company was the largest manufacturer of shoes in America in the early 20th century, but it went bankrupt in June 1939.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
CAL vs SEM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $790.1M | $1.4B |
| Net Profit | $2.4M | $20.2M |
| Gross Margin | 41.8% | — |
| Operating Margin | 1.5% | 4.6% |
| Net Margin | 0.3% | 1.4% |
| Revenue YoY | 6.6% | 6.4% |
| Net Profit YoY | -94.2% | 225.7% |
| EPS (diluted) | $0.07 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $790.1M | $1.4B | ||
| Q3 25 | $658.5M | $1.4B | ||
| Q2 25 | $614.2M | $1.3B | ||
| Q1 25 | $639.2M | $1.4B | ||
| Q4 24 | $740.9M | $1.3B | ||
| Q3 24 | $683.3M | $1.3B | ||
| Q2 24 | $659.2M | $1.3B | ||
| Q1 24 | $697.1M | $1.3B |
| Q4 25 | $2.4M | $20.2M | ||
| Q3 25 | $6.7M | $28.8M | ||
| Q2 25 | $6.9M | $40.6M | ||
| Q1 25 | $4.9M | $56.7M | ||
| Q4 24 | $41.4M | $-16.1M | ||
| Q3 24 | $30.0M | $55.6M | ||
| Q2 24 | $30.9M | $77.6M | ||
| Q1 24 | $55.7M | $96.9M |
| Q4 25 | 41.8% | — | ||
| Q3 25 | 43.4% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 43.0% | — | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 46.9% | — | ||
| Q1 24 | 43.9% | — |
| Q4 25 | 1.5% | 4.6% | ||
| Q3 25 | 1.4% | 5.4% | ||
| Q2 25 | 1.9% | 6.5% | ||
| Q1 25 | 1.2% | 8.3% | ||
| Q4 24 | 7.7% | 1.6% | ||
| Q3 24 | 6.2% | 4.3% | ||
| Q2 24 | 6.5% | 5.8% | ||
| Q1 24 | 4.4% | 9.0% |
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 1.0% | 2.1% | ||
| Q2 25 | 1.1% | 3.0% | ||
| Q1 25 | 0.8% | 4.2% | ||
| Q4 24 | 5.6% | -1.2% | ||
| Q3 24 | 4.4% | 4.4% | ||
| Q2 24 | 4.7% | 6.1% | ||
| Q1 24 | 8.0% | 7.3% |
| Q4 25 | $0.07 | $0.17 | ||
| Q3 25 | $0.20 | $0.23 | ||
| Q2 25 | $0.21 | $0.32 | ||
| Q1 25 | $0.17 | $0.44 | ||
| Q4 24 | $1.19 | $-0.12 | ||
| Q3 24 | $0.85 | $0.43 | ||
| Q2 24 | $0.88 | $0.60 | ||
| Q1 24 | $1.56 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $26.5M |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | $616.8M | $1.7B |
| Total Assets | $2.1B | $5.9B |
| Debt / EquityLower = less leverage | — | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $26.5M | ||
| Q3 25 | $191.5M | $60.1M | ||
| Q2 25 | $33.1M | $52.3M | ||
| Q1 25 | $29.6M | $53.2M | ||
| Q4 24 | $33.7M | $59.7M | ||
| Q3 24 | $51.8M | $191.5M | ||
| Q2 24 | $30.7M | $111.2M | ||
| Q1 24 | $21.4M | $92.6M |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | $616.8M | $1.7B | ||
| Q3 25 | $613.3M | $1.7B | ||
| Q2 25 | $605.2M | $1.7B | ||
| Q1 25 | $599.0M | $1.7B | ||
| Q4 24 | $598.3M | $1.7B | ||
| Q3 24 | $606.1M | $1.9B | ||
| Q2 24 | $570.3M | $1.4B | ||
| Q1 24 | $560.6M | $1.4B |
| Q4 25 | $2.1B | $5.9B | ||
| Q3 25 | $2.2B | $5.7B | ||
| Q2 25 | $1.9B | $5.7B | ||
| Q1 25 | $1.9B | $5.7B | ||
| Q4 24 | $2.0B | $5.6B | ||
| Q3 24 | $2.0B | $8.0B | ||
| Q2 24 | $1.9B | $7.9B | ||
| Q1 24 | $1.8B | $7.9B |
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $64.3M |
| Free Cash FlowOCF − Capex | $-12.4M | $5.2M |
| FCF MarginFCF / Revenue | -1.6% | 0.4% |
| Capex IntensityCapex / Revenue | 1.4% | 4.2% |
| Cash ConversionOCF / Net Profit | -0.50× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $14.4M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $64.3M | ||
| Q3 25 | $47.3M | $175.3M | ||
| Q2 25 | $-5.7M | $110.3M | ||
| Q1 25 | $28.7M | $-3.5M | ||
| Q4 24 | $-39.8M | $125.4M | ||
| Q3 24 | $79.6M | $181.0M | ||
| Q2 24 | $36.1M | $278.2M | ||
| Q1 24 | $43.0M | $-66.7M |
| Q4 25 | $-12.4M | $5.2M | ||
| Q3 25 | $35.0M | $122.2M | ||
| Q2 25 | $-26.2M | $45.6M | ||
| Q1 25 | $18.0M | $-55.8M | ||
| Q4 24 | $-57.4M | $62.0M | ||
| Q3 24 | $68.5M | $130.3M | ||
| Q2 24 | $26.3M | $222.6M | ||
| Q1 24 | $32.4M | $-119.2M |
| Q4 25 | -1.6% | 0.4% | ||
| Q3 25 | 5.3% | 9.0% | ||
| Q2 25 | -4.3% | 3.4% | ||
| Q1 25 | 2.8% | -4.1% | ||
| Q4 24 | -7.7% | 4.7% | ||
| Q3 24 | 10.0% | 10.2% | ||
| Q2 24 | 4.0% | 17.4% | ||
| Q1 24 | 4.6% | -9.0% |
| Q4 25 | 1.4% | 4.2% | ||
| Q3 25 | 1.9% | 3.9% | ||
| Q2 25 | 3.3% | 4.8% | ||
| Q1 25 | 1.7% | 3.9% | ||
| Q4 24 | 2.4% | 4.8% | ||
| Q3 24 | 1.6% | 4.0% | ||
| Q2 24 | 1.5% | 4.3% | ||
| Q1 24 | 1.5% | 4.0% |
| Q4 25 | -0.50× | 3.19× | ||
| Q3 25 | 7.05× | 6.09× | ||
| Q2 25 | -0.81× | 2.72× | ||
| Q1 25 | 5.82× | -0.06× | ||
| Q4 24 | -0.96× | — | ||
| Q3 24 | 2.66× | 3.25× | ||
| Q2 24 | 1.17× | 3.59× | ||
| Q1 24 | 0.77× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
